Zhimin Fan

Prof. Zhimin Fan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
GZGuoxue Zhu
Guoxue Zhu
YWYi Wang
Yi Wang
WWWang Wang
Wang Wang
FSFang Shang
Fang Shang
BPBin Pei
Bin Pei
ZFZhimin Fan
Zhimin Fan
Background: Colorectal cancer (CRC) is one of the most common malignant gastrointestinal cancers in the world with a 5-year survival rate of approximately 68%. Although researchers accumulated many scientific studies, its pathogenesis remains unclear yet. Detecting and removing these malignant polyps promptly is the most effective method in CRC prevention. Therefore, the analysis and disposal of malignant polyps is conducive to preventing CRC.Methods: In the study, metabolic profiling as well as diagnostic biomarkers for CRC was investigated using untargeted GC-MS-based metabolomics methods to explore the intervention approaches. In order to better characterize the variations of tissue and serum metabolic profiles, orthogonal partial least-square discriminant analysis was carried out to further identify significant features. The key differences in tR–m/z pairs were screened by the S-plot and VIP value from OPLS-DA. Identified potential biomarkers were leading in the KEGG in finding interactions, which show the relationships among these signal pathways.Results: Finally, 17 tissue and 13 serum candidate ions were selected based on their corresponding retention time, p-value, m/z, and VIP value. Simultaneously, the most influential pathways contributing to CRC were inositol phosphate metabolism, primary bile acid biosynthesis, phosphatidylinositol signaling system, and linoleic acid metabolism.Conclusions: The preliminary results suggest that the GC-MS-based method coupled with the pattern recognition method and understanding these cancer-specific alterations could make it possible to detect CRC early and aid in the development of additional treatments for the disease, leading to improvements in CRC patients’ quality of life.

11 December 2021 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
SXShaohua Xu
Shaohua Xu
RFRuolan Fan
Ruolan Fan
LWLu Wang
Lu Wang
WHWeishen He
Weishen He
HGHaixia Ge
Haixia Ge
ZFZhimin Fan
Zhimin Fan
Using STAT3 inhibitors as a potential strategy in cancer therapy have attracted much attention. Recently, celastrol has been reported that it could directly bind to and suppress the activity of STAT3 in the cardiac dysfunction model. To explore more effective STAT3 inhibiting anti-tumour drug candidates, we synthesised a series of celastrol derivatives and biologically evaluated them with several human cancer cell lines. The western blotting analysis showed that compound 4 m, the most active derivative, could suppress the STAT3’s phosphorylation as well as its downstream genes. SPR analysis, molecular docking and dynamics simulations’ results indicated that the 4m could bind with STAT3 protein more tightly than celastrol. Then we found that the 4m could block cell-cycle and induce apoptosis on HCT-116 cells. Furthermore, the anti-tumour effect of 4m was verified on colorectal cancer organoid. This is the first research that discovered effective STAT3 inhibitors as potent anti-tumour agents from celastrol derivatives.

5 September 2025 in Gut Microbes
Verified
Journal Article
Open access
RZRui Zhang
Rui Zhang
MLMingxiao Li
Mingxiao Li
HTHui Tan
Hui Tan
JLJianyao Liu
Jianyao Liu
LWLu Wang
Lu Wang
JLJi-Hua Liu
Ji-Hua Liu
Gut microbiota dysbiosis is strongly linked to colorectal cancer (CRC), but reliable early diagnostic markers remain elusive. This study investigates the role of a novel Shigella flexneri strain in CRC pathogenesis. Metabolomic analysis of CRC patient feces identified elevated agmatine levels. A unique agmatine-producing strain (S. flexneri C.11) was isolated and validated in cell models and pseudo-sterile mice. Affinity fishing combined with HPLC-QTOF-MS characterized bacterial metabolites, while RNA sequencing elucidated mechanistic pathways. Repeated S. flexneri C.11 exposure-induced DNA damage and inflammatory-to-neoplastic transformation. Three genotoxic cyclodipeptides (CDP1-3) were identified, driving malignant transformation and accelerating colitis-associated tumorigenesis. Mechanistically, S. flexneri C.11 upregulated ERBB3, activating the PI3K-AKT pathway. Clinically, combined detection of S. flexneri C.11 and its metabolites differentiated CRC patients from healthy controls (AUC = 0.887), suggesting its potential as noninvasive diagnostic biomarkers for CRC. We identify S. flexneri C.11 as a pro-carcinogenic pathogen and propose ERBB3/PI3K - AKT signaling as a therapeutic target.

4 July 2025 in Biochemical Pharmacology
Verified
Journal Article
Closed access
JCJingwei Cui
Jingwei Cui
HCHao Chen
Hao Chen
YCYuru Chen
Yuru Chen
BZBingwen Zhou
Bingwen Zhou
CHChuyue Huang
Chuyue Huang
LWLu Wang
Lu Wang

12 September 2024 in Heliyon
Verified
Journal Article
Open access
YWYu Wang
Yu Wang
HGHao Ge
Hao Ge
YZYi Zhang
Yi Zhang
PWPei Wang
Pei Wang
HZHaoran Zhao
Haoran Zhao
ZFZhimin Fan
Zhimin Fan
Colorectal cancer (CRC) is a malignant tumor with a high incidence, ranking first among gastrointestinal malignancies. We investigated the impact of polyphyllin I (PPI), a natural compound found in Paris polyphylla, on CRC. PPI has been documented to exhibit anticancer activity against various tumors. This study aimed to assess the effects of PPI on colorectal cancer and explore its potential mechanisms. Our research demonstrated that PPI inhibited proliferation, promoted apoptosis, and induced G2 cell-cycle arrest in a dose-dependent manner. Additionally, our results indicated that PPI suppressed Notch signaling by downregulating the Notch1 receptor, its ligand Jagged1, and the downstream target Hes1 expression. Furthermore, we confirmed the antitumor effect of PPI on patient-derived organoids. In conclusion, our study indicates that PPI impedes the growth of colon cancer by suppressing the Notch signaling pathway.

27 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BZBingwen Zhou
Bingwen Zhou
QLQingrui Liu
Qingrui Liu
CHChuyue Huang
Chuyue Huang
HCHao Chen
Hao Chen
PWPei Wang
Pei Wang
ZFZhimin Fan
Zhimin Fan
The adenoma-adenocarcinoma pathway represents a crucial mechanism underlying the development of colorectal precancerous lesions, encompassing approximately 85%-90% of colorectal cancer (CRC). Elucidating the molecular mechanisms underlying colorectal cancer progression is of paramount importance for achieving early and accurate diagnosis as well as effective treatment. We collected peripheral blood mononuclear cells (PBMC) from healthy controls, adenoma patients, and adenocarcinoma patients, and performed transcriptomic profiling to characterize dynamic gene expression during carcinogenesis. Diagnostic potential was assessed using receiver operating characteristic (ROC) analysis, and a random-forest model was trained to classify disease status. The screening identified genes with consistent expression changes as potential early diagnostic markers, and further exploration of their functions and significance in CRC is conducted through analysis of the TCGA database. The findings revealed that the progression of precancerous lesions in the “Normal-Adenoma-Cancer” (N-A-C) sequence was accompanied by a sustained enhancement of the immune response. Notably, HECW2, WARS1, SLC16A3, SECTM1, IFITM3, ADAMTSL4, FCGR1A, F2RL1, OPLAH, SERPINA1, FCGR1CP showed consistent upregulation with promising diagnostic performance. In our PBMC cohort, the random-forest classifier achieved an accuracy of 93.62%, indicating potential for distinguishing cancer from precancerous lesions. The bioinformatics analysis revealed a significant association of these genes with DNA methyltransferase, DNA mismatch repair, m6A regulator, tumor mutational burden (TMB) and microsatellite instability (MSI). Furthermore, a detailed analysis was further performed on WARS1. In the “N-A-C” sequence, WARS1 exhibited a significant upregulation in both blood and tissues, demonstrating a positive correlation with augmented infiltration of immune cells, activation of stromal and immune responses, as well as heightened activity during the cancer immune cycle. However, it demonstrates a declining trend in the progression of CRC from stage I to IV, which may be intricately associated with the metastasis of CRC. The WARS1 can serve as a reliable indicator of the immune response in CRC, thereby demonstrating its potential to impede tumorigenesis or metastasis.